However, to date, none of these markers are used in clinical practice.<h4>Methods</h4>We conducted a systematic review of PubMed and EMBASE to assess the number and level of evidence of published DNA methylation markers for hormone receptor-positive breast cancer. The gene discussed is NR4A1; the disease is breast carcinoma.